On August 18, 2026, ResMed Inc (ASX:RMD) shares were trading at AUD 31.18, down 1.42%. The company reported a strong financial performance for Q4 FY26, with quarterly revenue of US$1.464 billion, a 9% year-on-year increase, and FY26 revenue of US$5.7 billion, up 10%. ResMed’s focus on sleep health and respiratory care technology is supported by its digital health initiatives and recent acquisitions, such as Noctrix Health. Investors are closely watching the company’s product demand, innovation, and overall market trends in the healthcare technology sector.
Disclaimer: This summary is written by AI, which can make mistakes. Please follow up on any news information from additional sources.
Link to original article source: https://kalkine.com.au/news/healthcare/resmed-asxrmd-faces-market-attention-as-healthcare-technology-portfolio-continues-to-evolve
